A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I

Dorre A. Grueneberg, R. William Henry, Andrew W. Brauer, +4

Genes & Development

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Shahper N. Khan, A. Jankowska, Reda Z. Mahfouz, +16

Leukemia

Histone ModificationsTumor BiologyChromatinHistone H3Hematological Malignancy +11

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

Venugopalan Cheriyath, Keith B. Glaser, Jeffrey F. Waring, +3

Journal of Clinical Investigation

Chemoprevention StrategyIfn-alpha2b ApoptosisApoptosisImmunologyCell Death +16

TFII-I Enhances Activation of the c-<i>fos</i>Promoter through Interactions with Upstream Elements

Dae-Won Kim, Venugopalan Cheriyath, Ananda L. Roy, +1

Molecular and Cellular Biology

Regulation of Nuclear Localization and Transcriptional Activity of TFII-I by Bruton’s Tyrosine Kinase

Carl D. Novina, Sanjay Kumar, Urmila D. Bajpai, +5

Molecular and Cellular Biology

Molecular RegulationTyrosine KinaseImmunologyMolecular BiologyImmunologic Mechanism +22

Identification of TFII-I as the Endoplasmic Reticulum Stress Response Element Binding Factor ERSF: Its Autoregulation by Stress and Interaction with ATF6

Ronald C. Parker, Trevor Phan, Peter Baumeister, +4

Molecular and Cellular Biology

Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression

Wioleta Łuszczek, Venugopalan Cheriyath, Tarek Mekhail, +1

Molecular Cancer Therapeutics

G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS

Venugopalan Cheriyath, Jaspreet Kaur, Anne Davenport, +3

British Journal of Cancer

Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of<i>p21</i>Gene Expression Leading to G2/M Cycle Arrest

Sivakumar Vijayaraghavalu, Josephine K. Dermawan, Venugopalan Cheriyath, +1

Molecular Pharmaceutics

Breast OncologyChemoprevention StrategyCancer BiologyDrug ResistanceHighly Synergistic Effect +15

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Venugopalan Cheriyath, M A Kuhns, Barbara Jacobs, +5

Oncogene

Estrogen-induced Survival ProteinBreast OncologyPoor OutcomesMedicineBreast Cancer +6